Blockade of atrial angiotensin II type 1 receptors: a novel antiarrhythmic strategy to prevent atrial fibrillation?

J Am Coll Cardiol. 2003 Jun 18;41(12):2205-6. doi: 10.1016/s0735-1097(03)00469-8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Atrial Fibrillation / prevention & control*
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Disease Models, Animal
  • Dogs
  • Heart Conduction System / drug effects*
  • Humans
  • Receptors, Angiotensin / therapeutic use*
  • Renin-Angiotensin System / drug effects
  • Tetrazoles / pharmacology
  • Tetrazoles / therapeutic use*
  • Ventricular Remodeling / drug effects*

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Receptors, Angiotensin
  • Tetrazoles
  • candesartan